Cimzia®
Cimzia® (certolizumab pegol) is a monoclonal antibody that helps the body’s immune system by targeting and destroying certain cells helping to protect healthy cells from damage. Specifically it is a tumor necrosis factor blocker (TNF) for treatment of Crohn’s Disease Rheumatoid Arthritis (RA) Psoriatic Arthritis Ankylosing Spondylitis Non-radiographic Axial Spondylarthritis.
For more information, visit the patient website for this drug. Speak with your healthcare provider to learn if this drug is right for you.
WHAT IT TREATS: |
MANUFACTURER: UCB Group |
CLASS: TNF alfa inhibitors |
HOW ADMINISTERED: Injection |
FREQUENCY: Administered as an initial dose, then two weeks later, four weeks, and every four weeks after. |
Length of infusion: N/A |
FOR MORE INFORMATION: |
